MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Cefuroxime

Cefuroxime 250mg tablets

Use with caution

Stability notes for Cefuroxime 250mg tablets

Protect from moisture. Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the product Cefuroxime 250mg tablets (Sandoz Ltd).

Suppliers (9) of Cefuroxime 250mg tablets
Cefuroxime 250mg tablets (A A H Pharmaceuticals Ltd)
Cefuroxime 250mg tablets (Alliance Healthcare (Distribution) Ltd)
Cefuroxime 250mg tablets (CST Pharma Ltd)
Cefuroxime 250mg tablets (Medihealth (Northern) Ltd)
Cefuroxime 250mg tablets (Phoenix Healthcare Distribution Ltd)
Cefuroxime 250mg tablets (Sandoz Ltd)
Cefuroxime 250mg tablets (Sigma Pharmaceuticals Plc)
Zinnat 250mg tablets (CST Pharma Ltd)
Zinnat 250mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.